Longevity Biomedical: Late Stage, Diversified Pipeline of Therapeutic Candidates Across Ophthalmology, Cardiovascular Disease and Soft Tissue Reconstruction and Repair >FTII
Longevity Biomedical: Late Stage, Diversified Pipeline of Therapeutic Candidates Across Ophthalmology, Cardiovascular Disease and Soft Tissue Reconstruction and Repair >FTII
Longevity Biomedical：眼科醫療、心血管疾病和軟組織修復等領域的治療候選藥物多樣化的後期研發項目 > FTII
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登入免費觀看全文
登入/註冊
資訊熱榜
更新時間